Aflac Incorporated (NYSE:AFL) Shares Acquired by Copperwynd Financial LLC

Copperwynd Financial LLC lifted its stake in Aflac Incorporated (NYSE:AFL) by 3.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,029 shares of the financial services provider’s stock after buying an additional 109 shares during the period. Copperwynd Financial LLC’s holdings in Aflac were worth $289,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the stock. Dimensional Fund Advisors LP grew its position in shares of Aflac by 6.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock valued at $429,319,000 after buying an additional 285,576 shares during the last quarter. APG Asset Management N.V. grew its position in shares of Aflac by 1.3% in the 2nd quarter. APG Asset Management N.V. now owns 2,429,316 shares of the financial services provider’s stock valued at $202,437,000 after buying an additional 31,752 shares during the last quarter. ProShare Advisors LLC grew its position in shares of Aflac by 5.6% in the 2nd quarter. ProShare Advisors LLC now owns 2,220,125 shares of the financial services provider’s stock valued at $198,279,000 after buying an additional 117,504 shares during the last quarter. Nordea Investment Management AB grew its position in shares of Aflac by 6.7% in the 1st quarter. Nordea Investment Management AB now owns 1,806,475 shares of the financial services provider’s stock valued at $155,140,000 after buying an additional 113,226 shares during the last quarter. Finally, Envestnet Asset Management Inc. grew its position in shares of Aflac by 27.6% in the 2nd quarter. Envestnet Asset Management Inc. now owns 1,243,189 shares of the financial services provider’s stock valued at $111,029,000 after buying an additional 268,694 shares during the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Stock Up 0.5 %

Shares of NYSE:AFL opened at $110.59 on Monday. The company has a market cap of $62.84 billion, a price-to-earnings ratio of 12.21, a PEG ratio of 2.60 and a beta of 0.95. The firm’s 50-day simple moving average is $104.50 and its 200-day simple moving average is $92.98. The company has a quick ratio of 0.10, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a fifty-two week low of $74.89 and a fifty-two week high of $111.14.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.23. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $4.10 billion. During the same quarter in the previous year, the firm earned $1.58 earnings per share. The business’s quarterly revenue was down .7% compared to the same quarter last year. As a group, equities research analysts predict that Aflac Incorporated will post 6.75 earnings per share for the current year.

Aflac Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Investors of record on Wednesday, August 21st were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.81%. The ex-dividend date was Wednesday, August 21st. Aflac’s dividend payout ratio (DPR) is 22.08%.

Insider Activity at Aflac

In related news, Director Thomas J. Kenny sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the sale, the director now owns 18,158 shares in the company, valued at $1,796,552.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Barclays started coverage on shares of Aflac in a research report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 target price on the stock. UBS Group raised their price objective on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 14th. Evercore ISI raised their price objective on shares of Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a research report on Thursday. Morgan Stanley raised their price objective on shares of Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research report on Monday, August 19th. Finally, Jefferies Financial Group lowered their price objective on shares of Aflac from $84.00 to $83.00 and set a “hold” rating on the stock in a research report on Friday, June 28th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, Aflac presently has an average rating of “Hold” and a consensus target price of $93.36.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.